X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (134) 134
acid-related disorders (123) 123
proton pump inhibitors (79) 79
pharmacology & pharmacy (72) 72
gastroenterology & hepatology (61) 61
lansoprazole (56) 56
omeprazole (52) 52
male (51) 51
female (47) 47
index medicus (47) 47
2-pyridinylmethylsulfinylbenzimidazoles (44) 44
animals (43) 43
omeprazole - analogs & derivatives (43) 43
gastroesophageal reflux - drug therapy (35) 35
adult (33) 33
gastroesophageal reflux disease (33) 33
proton pump inhibitor (33) 33
anti-ulcer agents - therapeutic use (28) 28
pantoprazole (28) 28
helicobacter pylori (27) 27
middle aged (27) 27
helicobacter infections - drug therapy (26) 26
helicobacter-pylori infection (26) 26
aged (25) 25
gastroesophageal-reflux disease (25) 25
double-blind (23) 23
omeprazole - therapeutic use (23) 23
pharmacokinetics (23) 23
gastroesophageal reflux (22) 22
rabeprazole (22) 22
adolescent (19) 19
management (19) 19
therapeutic use (19) 19
medicine & public health (18) 18
medicine, general & internal (18) 18
internal medicine (17) 17
proton pump inhibitors - therapeutic use (17) 17
acid-related diseases (16) 16
anti-ulcer agents - administration & dosage (16) 16
treatment outcome (16) 16
drug interactions (15) 15
anti-ulcer agents - pharmacokinetics (14) 14
double-blind method (14) 14
duodenal-ulcer (14) 14
efficacy (14) 14
omeprazole - adverse effects (14) 14
pharmacology (14) 14
proton-pump inhibitors (14) 14
anti-ulcer agents - pharmacology (13) 13
nonsteroidal antiinflammatory drugs (13) 13
omeprazole - administration & dosage (13) 13
omeprazole - pharmacology (13) 13
pharmacokinetic properties (13) 13
pharmacology/toxicology (13) 13
toxicology (13) 13
benzimidazoles - therapeutic use (12) 12
disease (12) 12
enzyme inhibitors - therapeutic use (12) 12
esophagitis (12) 12
functional dyspepsia (12) 12
peptic ulcer - drug therapy (12) 12
rats (12) 12
acid-related dyspepsia (11) 11
drug therapy, combination (11) 11
gastroenterology (11) 11
health aspects (11) 11
helicobacter-pylori (11) 11
peptic ulcer disease (11) 11
pharmacotherapy (11) 11
ranitidine (11) 11
anti-ulcer agents - adverse effects (10) 10
child (10) 10
dyspepsia - drug therapy (10) 10
omeprazole - pharmacokinetics (10) 10
pharmacological properties (10) 10
placebo-controlled trial (10) 10
prevalence (10) 10
time factors (10) 10
triple therapy (10) 10
anti-bacterial agents - therapeutic use (9) 9
area under curve (9) 9
dose-response relationship, drug (9) 9
esomeprazole (9) 9
gastric acid - secretion (9) 9
gastrointestinal diseases - drug therapy (9) 9
gerd (9) 9
mice (9) 9
peptic ulcer (9) 9
sulfoxides - therapeutic use (9) 9
administration, oral (8) 8
article (8) 8
benzimidazoles - administration & dosage (8) 8
chemistry, medicinal (8) 8
child, preschool (8) 8
digestive system diseases (8) 8
drug therapy (8) 8
duodenal ulcer (8) 8
dyspepsia (8) 8
gastro-oesophageal reflux disease (8) 8
helicobacter infections - complications (8) 8
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (178) 178
Japanese (25) 25
Spanish (6) 6
French (5) 5
Chinese (2) 2
German (2) 2
Croatian (1) 1
Italian (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drugs, ISSN 0012-6667, 10/2002, Volume 62, Issue 10, pp. 1503 - 1538
Esomeprazole (S-isomer of omeprazole), the first single optical isomer proton pump inhibitor, generally provides better acid control than current racemic... 
Helicobacter pylori infections, treatment | Oesophagitis, treatment | Gastro oesophageal reflux, treatment | Drug evaluations | Esomeprazole, general | Proton pump inhibitors, general | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacodynamics | Peptic ulcer disease | Helicobacter pylori | Acid-related dyspepsia | Esomeprazole | Gastro-oesophageal reflux disease | Duodenal ulcer | Gastric ulcer | Pharmacokinetics | Therapeutic use | Proton pump inhibitor | esomeprazole | DUODENAL-ULCER DISEASE | HEALED EROSIVE ESOPHAGITIS | pharmacodynamics | duodenal ulcer | CLINICAL EFFICACY | GASTROESOPHAGEAL REFLUX DISEASE | gastric ulcer | proton pump inhibitor | acid-related dyspepsia | PROTON-PUMP INHIBITORS | gastro-oesophageal reflux disease | RANDOMIZED CONTROLLED TRIAL | PHARMACOLOGICAL PROPERTIES | HELICOBACTER-PYLORI INFECTION | pharmacokinetics | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | QUALITY-OF-LIFE | therapeutic use | peptic ulcer disease | Enzyme Inhibitors - adverse effects | Omeprazole - therapeutic use | Proton Pump Inhibitors | Humans | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Treatment Outcome | Enzyme Inhibitors - therapeutic use | Randomized Controlled Trials as Topic | Enzyme Inhibitors - pharmacokinetics | Omeprazole - pharmacology | Databases, Bibliographic | Gastroesophageal Reflux - drug therapy | Omeprazole - analogs & derivatives
Journal Article
Annual Reports in Medicinal Chemistry, ISSN 0065-7743, 2013, Volume 48, pp. 169 - 182
Current therapies for inflammatory and autoimmune diseases include general immuosuppressive agents and newer biologics targeting proinflammatory cytokines.... 
IL-17 | Retinoic acid-related orphan receptor | Autoimmune | Antagonist | IL-23 | Inflammatory disease | RORγt | PATHOGENESIS | POTENT | CHEMISTRY, MEDICINAL | STRUCTURAL BASIS | PHARMACOLOGY & PHARMACY | INNATE LYMPHOID-CELLS | DIFFERENTIATION | IDENTIFICATION | INSULIN SENSITIVITY | EXPRESSION | PSORIASIS | TH17 CELLS
Journal Article
Drugs, ISSN 0012-6667, 2001, Volume 61, Issue 15, pp. 2327 - 2356
Rabeprazole is an inhibitor of the gastric proton pump. It causes dose-dependent inhibition of acid secretion.In 8-week studies, among patients with... 
Gastric ulcer, treatment | Gastro oesophageal reflux, treatment | Duodenal ulcer, treatment | Barrett's oesophagus, treatment | Drug evaluations | Proton pump inhibitors, general | Helicobacter pylori infections, treatment | Rabeprazole, general | Zollinger Ellison syndrome, treatment | Antibacterials, therapeutic use | Gastric antisecretories, general | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacodynamics | Helicobacter pylori infection | Peptic ulcer disease | Gastro-oesophageal reflux disease | Acid-related disorders | Rabeprazole | Pharmacokinetics | Therapeutic use | acid-related disorders | pharmacodynamics | GASTROESOPHAGEAL REFLUX DISEASE | S-MEPHENYTOIN 4'-HYDROXYLATION | gastro-oesophageal reflux disease | 24-H INTRAGASTRIC ACIDITY | HELICOBACTER-PYLORI INFECTION | PROTON PUMP INHIBITOR | pharmacokinetics | HEALTHY MALE-SUBJECTS | DOUBLE-BLIND | ORAL RABEPRAZOLE | PHARMACOLOGY & PHARMACY | 40 MG RABEPRAZOLE | TOXICOLOGY | rabeprazole | therapeutic use | peptic ulcer disease | OMEPRAZOLE 20 MG | Drug Costs | Steroid Hydroxylases - metabolism | Humans | Helicobacter pylori - pathogenicity | Cytochrome P-450 Enzyme System - metabolism | Helicobacter Infections - complications | Steroid 16-alpha-Hydroxylase | Anti-Ulcer Agents - pharmacokinetics | Drug Interactions | Helicobacter Infections - drug therapy | Anti-Ulcer Agents - pharmacology | Gastroesophageal Reflux - drug therapy | Steroid Hydroxylases - genetics | Gastrins - blood | Zollinger-Ellison Syndrome - drug therapy | Drug Administration Schedule | Stomach Ulcer - drug therapy | Benzimidazoles - pharmacokinetics | Cytochrome P-450 Enzyme System - genetics | 2-Pyridinylmethylsulfinylbenzimidazoles | Benzimidazoles - pharmacology | Duodenal Ulcer - drug therapy | Aryl Hydrocarbon Hydroxylases | Omeprazole - analogs & derivatives
Journal Article
Chinese Journal of Gastroenterology, ISSN 1008-7125, 02/2017, Volume 22, Issue 2, pp. 115 - 117
Journal Article
World Chinese Journal of Digestology, ISSN 1009-3079, 2014, Volume 22, Issue 15, pp. 2073 - 2080
Journal Article
Drugs, ISSN 0012-6667, 2002, Volume 62, Issue 7, pp. 1091 - 1118
Esomeprazole, the S-isomer of omeprazole, is the first proton pump inhibitor to be developed as a single optical isomer. It provides better acid control than... 
Helicobacter pylori infections, treatment | Antisecretories, general | Gastro oesophageal reflux, treatment | Esomeprazole, general | Gastrointestinal disorders, treatment | Proton pump inhibitors, general | Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Pharmacodynamics | Peptic ulcer disease | Helicobacter pylori | Acid-related dyspepsia | Esomeprazole | Gastro-oesophageal reflux disease | Duodenal ulcer | Gastric ulcer | Pharmacokinetics | Therapeutic use | Proton pump inhibitor | esomeprazole | HEALED EROSIVE ESOPHAGITIS | pharmacodynamics | duodenal ulcer | GASTROESOPHAGEAL REFLUX DISEASE | gastric ulcer | proton pump inhibitor | acid-related dyspepsia | PROTON-PUMP INHIBITORS | PEPTIC-ULCER DISEASE | H-2-RECEPTOR ANTAGONISTS | gastro-oesophageal reflux disease | RANDOMIZED CONTROLLED TRIAL | PHARMACOLOGICAL PROPERTIES | HELICOBACTER-PYLORI INFECTION | pharmacokinetics | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | TOXICOLOGY | QUALITY-OF-LIFE | therapeutic use | peptic ulcer disease | Anti-Ulcer Agents - therapeutic use | Omeprazole - therapeutic use | Proton Pump Inhibitors | Humans | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Omeprazole - adverse effects | Omeprazole - pharmacokinetics | Enzyme Inhibitors - therapeutic use | Anti-Ulcer Agents - administration & dosage | Anti-Ulcer Agents - pharmacokinetics | Animals | Gastrointestinal Diseases - drug therapy | Helicobacter Infections - drug therapy | Gastroesophageal Reflux - drug therapy | Omeprazole - analogs & derivatives
Journal Article
Acta Biomedica, ISSN 0392-4203, 2018, Volume 89, Issue 8S, pp. 40 - 43
Gastroesophageal reflux disease (GERD) is due to the chronic exposure of the esophageal mucosa to acid secretion from the stomach. Helicobacter pylori (H.p.)... 
Acid-related disorders | GERD | Esophagiti | Helicobacter pylori | Gastroesophageal reflux disease | acid-related disorders | Review | gastroesophageal reflux disease | esophagitis
Journal Article
Frontline Gastroenterology, ISSN 2041-4137, 2018, Volume 9, Issue 3, pp. 214 - 220
The cervical inlet patch is an island of heterotopic gastric mucosa, most commonly found in the proximal oesophagus. Its importance as a cause of throat... 
oesophageal disorders | Oesophagus and Stomach | acid-related diseases
Journal Article